MetLife Investment Advisors »

Cardlytics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Cardlytics (CDLX) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Cardlytics

Tip: Access up to 7 years of quarterly data

All positions including Cardlytics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cardlytics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $166k 18k 9.21
2023-09-30 $297k 18k 16.50
2023-06-30 $114k 18k 6.32
2022-12-31 $101k 18k 5.78
2022-09-30 $164k 18k 9.40
2022-06-30 $390k 18k 22.31
2022-03-31 $961k 18k 54.98
2021-12-31 $728k 11k 66.09
2021-09-30 $925k 11k 83.97
2021-06-30 $1.4M 11k 126.91
2021-03-31 $1.2M 11k 109.70
2020-12-31 $1.5M 11k 142.77
2020-09-30 $812k 12k 70.55
2020-06-30 $805k 12k 69.95
2020-03-31 $232k 6.6k 34.92
2019-12-31 $418k 6.6k 62.92
2019-09-30 $223k 6.6k 33.57
2019-06-30 $173k 6.6k 25.98